You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 4, April 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neonatology and Infant Care
 •Alert me on articles by topic

Selection of Neonates for Neuroprotective Therapies

One Set of Criteria Applied to a Population

Karin B. Nelson, MD; Judith K. Grether, PhD

Arch Pediatr Adolesc Med. 1999;153:393-398.

Objectives  To estimate the proportion of children with cerebral palsy (CP) who had signs of "birth asphyxia" in the early hours of life, and to examine the nature of the illnesses in those infants.

Design  Population-based case-control study.

Setting  All births in 4 northern California counties, 1983 through 1985.

Subjects  Eighty-four full-term singleton children surviving to age 3 years with spastic CP and 366 full-term control children.

Main Outcome Measure  Moderate or severe spastic CP.

Results  Of 84 full-term children with spastic CP, 18 had 5-minute Apgar scores of less than 6, 20 required intubation for ventilation in the delivery room, and 5 had an initial blood pH of 7.00 or less. Three (3.6%) of the 84 children had all 3 signs evaluated, a prevalence of 0.019 per 1000 survivors. All 3 had neonatal seizures. When we relaxed the pH cutoff to 7.10 or less, there were 19 children with CP who met at least 2 criteria. Eight of these 19 infants were born in level I facilities. In these children there was evidence of maternal or infant infection (n = 7); abnormal coagulation factor, thrombosis, or thrombocytopenia (n = 8); or other complication predating birth (n = 9).

Conclusions  Neuroprotective therapy offered to neonates with these early characteristics, even if perfectly effective, would be unlikely to prevent most CP. Most of these depressed infants with CP had nonasphyxial conditions that may have contributed to adverse neurological outcome.


From the Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Md (Dr Nelson); and the California Birth Defects Monitoring Program, California Department of Health Services, Emeryville, (Dr Grether).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Postasphyxial Hypoxic-Ischemic Encephalopathy in Neonates: Outcome Prediction Rule Within 4 Hours of Birth
Shah et al.
Arch Pediatr Adolesc Med 2006;160:729-736.
ABSTRACT | FULL TEXT  

Topical Review: Fetal and Neonatal Neurologic Case Histories: Assessment of Brain Disorders in the Context of Fetal-Maternal-Placental Disease: Part 2: Neonatal Neurologic Consultations in the Context of Adverse Antepartum and Intrapartum Events
Scher
J Child Neurol 2003;18:155-164.
ABSTRACT  

Practice parameter: Neuroimaging of the neonate: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Miller et al.
Neurology 2002;59:1663-1664.
FULL TEXT  

Practice parameter: Neuroimaging of the neonate: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Ment et al.
Neurology 2002;58:1726-1738.
ABSTRACT | FULL TEXT  

First, Observe the Patient
Palmer
Arch Pediatr Adolesc Med 2002;156:422-423.
FULL TEXT  

Line-Scan Diffusion Imaging of Term Neonates with Perinatal Brain Ischemia
Barkovich and Ferriero
Am. J. Neuroradiol. 1999;20:1577-1579.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.